Medtronic launches leonine pump education effort

Share this article:
Medtronic launches leonine pump education effort
Medtronic launches leonine pump education effort
Medtronic launched a video contest aimed at diabetic kids, who use an insulin pump, and their parents.

The contest features Lenny the Lion, a character that Medtronic has used for children's diabetes education in Europe and is now introducing in the US. Contestants must download and print out a kit containing cutouts of Lenny and incorporate them into their 2-3 minute videos depicting Lenny educating children about diabetes. The last day for submissions is March 1, and shortlisted videos will be posted for voting later in the month.

The contest does not mention any products. Medtronic makes the Paradigm Real-Time insulin pump, which holds upwards of two-thirds of the US market and around 60% of the global market.

In costume form, Lenny looks a little like he fell off The Wiggles tour bus. The story goes that he was diagnosed with diabetes at a young age and uses an insulin pump. Medtronic said he'll soon have his own US website and iPhone apps, and will be putting in appearances at diabetes camps, conferences and pediatric clinics.

"We chose the lion character because Lenny represents a brave, courageous and active figure that is at the same time a cuddly figure that kids can relate to," said a Medtronic spoke. "The idea is that Lenny teaches kids how to live a healthy and active life even with diabetes."
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...